Business
The Extraordinary General Meeting of AlzeCure Pharma AB Approved the Decision on the New Issue of Shares
STOCKHOLM, SE / ACCESS Newswire / July 2, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - At an extraordinary general meeting in AlzeCure Pharma AB on July 2, 2025, the shareholders decided to approve the board's previous decision on the preferential ...
About this update from Alzecure Pharma Ab
[{"type":"text","content":"STOCKHOLM, SE / ACCESS Newswire / July 2, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - At an extraordinary general meeting in AlzeCure Pharma AB on July 2, 2025, the shareholders decided to approve the board's previous decision on the preferential issue of shares.","length":270,"tagName":"p"},{"type":"text","content":"The general meeting approved the board's previous decision of June 16, 2025 regarding the preferential issue of shares on the following main terms:","length":151,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"The company's share capital must be increased by a maximum of SEK 551,845 through a new issue of a maximum of 22,073,800 shares.","length":132,"tagName":"p"}]},{"val":[{"type":"text","content":"The company's shareholders shall have preferential rights to subscribe for the new shares, whereby one (1) existing share in the company shall entitle to one (1) subscription right, and four (4) subscription rights shall entitle to subscription to one (1) share.","length":266,"tagName":"p"}]},{"val":[{"type":"text","content":"The record date for determining which shareholders are entitled to subscribe for the new shares with preferential rights shall be July 4, 2025.","length":143,"tagName":"p"}]},{"val":[{"type":"text","content":"The subscription price shall be SEK 2.20 per share.","length":51,"tagName":"p"}]},{"val":[{"type":"text","content":"Subscription for shares must take place during the period from and including July 8, 2025 to and including July 22, 2025. Subscription for shares with preferential rights (i.e. with the support of subscription rights) must take place through simultaneous payment. Subscription of shares without preferential rights (i.e. without the support of subscription rights) must take place on a subscription list. The board shall have the right to decide on an extension of the subscription period.","length":489,"tagName":"p"}]},{"val":[{"type":"text","content":"Payment for shares subscribed without pre-emptive rights (i.e. without the support of subscription rights) must be made no later than three banking days from the issuance of the notice of allocation (settlement note). The board shall, however, have the right to decide on an extension of the payment period.","length":307,"tagName":"p"}]},{"val":[{"type":"text","content":"Payment for subscribed...